• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族史与汉族人群导管原位癌和三阴性乳腺癌风险的病例对照研究。

Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study.

机构信息

Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.

出版信息

World J Surg Oncol. 2013 Oct 1;11:248. doi: 10.1186/1477-7819-11-248.

DOI:10.1186/1477-7819-11-248
PMID:24083544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3850692/
Abstract

BACKGROUND

The association between family history and risk of triple negative breast cancer and ductal carcinoma in situ (DCIS) has not been well investigated, especially in Asian populations. We investigated the association between family history and risk of DCIS or triple negative breast cancer in a Han Chinese population.

METHODS

A case-control study, comprising 926 breast cancer patients and 1,187 benign breast disease controls, was conducted in our hospital. Multivariate logistic regression was used to assess the relationships between family history and risk of DCIS or triple negative breast cancer.

RESULTS

Subjects with a family history of breast cancer had higher breast cancer risk than those without a family history (odds ratio (OR) = 2.11, 95% confidence interval (CI) = 1.26 to 3.52). Family history was not significantly associated with an increased risk of DCIS (OR = 1.27, 95% CI = 0.36 to 4.46), while family history was significantly associated with an increased risk of invasive breast cancer (OR = 2.22, 95% CI = 1.32 to 3.75), irrespective of triple negative breast cancer (OR = 3.35, 95% CI = 1.43 to 7.88) or non-triple negative breast cancer (OR = 2.14, 95% CI = 1.21 to 3.80).

CONCLUSION

Our results indicate that having a family history of breast cancer is associated with an increased risk of triple negative breast cancer with a magnitude of association similar to that for non-triple negative breast cancer. Furthermore, family history is not significantly associated with an increased risk of DCIS. Future cohort studies with larger sample sizes are still needed to explore these relationships.

摘要

背景

家族史与三阴性乳腺癌和导管原位癌(DCIS)风险之间的关联尚未得到很好的研究,尤其是在亚洲人群中。我们调查了家族史与汉族人群 DCIS 或三阴性乳腺癌风险之间的关系。

方法

在我院进行了一项病例对照研究,共纳入 926 例乳腺癌患者和 1187 例良性乳腺疾病对照。采用多变量 logistic 回归评估家族史与 DCIS 或三阴性乳腺癌风险之间的关系。

结果

有乳腺癌家族史的受试者患乳腺癌的风险高于无家族史者(比值比(OR)=2.11,95%置信区间(CI)=1.26 至 3.52)。家族史与 DCIS 风险增加无关(OR=1.27,95%CI=0.36 至 4.46),而家族史与浸润性乳腺癌风险增加显著相关(OR=2.22,95%CI=1.32 至 3.75),无论是否为三阴性乳腺癌(OR=3.35,95%CI=1.43 至 7.88)或非三阴性乳腺癌(OR=2.14,95%CI=1.21 至 3.80)。

结论

我们的研究结果表明,有乳腺癌家族史与三阴性乳腺癌风险增加相关,其关联程度与非三阴性乳腺癌相似。此外,家族史与 DCIS 风险增加无关。仍需要更大样本量的队列研究来进一步探讨这些关系。

相似文献

1
Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study.家族史与汉族人群导管原位癌和三阴性乳腺癌风险的病例对照研究。
World J Surg Oncol. 2013 Oct 1;11:248. doi: 10.1186/1477-7819-11-248.
2
Notch1 single nucleotide polymorphism rs3124591 is associated with the risk of development of invasive ductal breast carcinoma in a Chinese population.Notch1单核苷酸多态性rs3124591与中国人群浸润性导管癌的发生风险相关。
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4286-94. eCollection 2014.
3
Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.顺式作用超级增强子长非编码 RNA 作为早期乳腺癌的生物标志物。
Breast Cancer Res. 2021 Oct 30;23(1):101. doi: 10.1186/s13058-021-01479-8.
4
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.证实 5p12 是孕激素受体阳性、低级别乳腺癌的易感性位点。
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2222-31. doi: 10.1158/1055-9965.EPI-11-0569. Epub 2011 Jul 27.
5
HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component.HER2 阳性状态是广泛 DCIS 成分存在的乳腺导管原位癌伴发浸润的独立预测因子。
Pathol Res Pract. 2011 Jan 15;207(1):1-7. doi: 10.1016/j.prp.2010.08.005. Epub 2010 Nov 20.
6
Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.在病例对照和病例-病例分析中,纯癌与伴有原位成分的浸润性癌的乳腺癌风险因素关联有所不同。
Cancer Causes Control. 2016 Feb;27(2):183-98. doi: 10.1007/s10552-015-0696-z. Epub 2015 Nov 30.
7
Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.基于ERBB2状态的乳腺导管原位癌中的差异基因表达
Cancer Control. 2017 Jan;24(1):102-110. doi: 10.1177/107327481702400117.
8
Genomic landscape of ductal carcinoma in situ and association with progression.导管原位癌的基因组景观及其与进展的关联。
Breast Cancer Res Treat. 2019 Nov;178(2):307-316. doi: 10.1007/s10549-019-05401-x. Epub 2019 Aug 17.
9
Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer.同步导管原位癌和浸润性乳腺癌中具有可比性的癌症相关突变特征。
Cancer Rep (Hoboken). 2020 Jun;3(3):e1248. doi: 10.1002/cnr2.1248. Epub 2020 May 28.
10
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.人表皮生长因子受体 2 阳性导管原位癌患者后续原位和浸润性乳腺癌的风险。
Ann Oncol. 2015 Apr;26(4):682-687. doi: 10.1093/annonc/mdv013. Epub 2015 Jan 18.

引用本文的文献

1
Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer.乳腺癌危险因素对原发性乳腺癌临床相关预后生物标志物的影响。
Breast Cancer Res Treat. 2021 Sep;189(2):483-495. doi: 10.1007/s10549-021-06294-5. Epub 2021 Jun 29.
2
SNHG1 Long Noncoding RNA is Potentially Up-Regulated in Colorectal Adenocarcinoma.SNHG1 长非编码 RNA 可能在结直肠腺癌中上调。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):897-901. doi: 10.31557/APJCP.2020.21.4.897.
3
A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors.亚洲乳腺癌流行病学研究综述:关注危险因素。
Asian Pac J Cancer Prev. 2020 Apr 1;21(4):867-880. doi: 10.31557/APJCP.2020.21.4.867.
4
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.西班牙具有遗传风险特征的乳腺癌发病率:来自GEICAM“阿尔莫III”回顾性研究的分析
PLoS One. 2017 Oct 6;12(10):e0184181. doi: 10.1371/journal.pone.0184181. eCollection 2017.
5
Family history in breast cancer in São Luís, Maranhão, Brazil.巴西马拉尼昂州圣路易斯市乳腺癌家族病史。
BMC Res Notes. 2016 Mar 10;9:155. doi: 10.1186/s13104-015-1471-7.
6
Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women.非裔美国女性癌症家族史与乳腺癌亚型的关系
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):366-73. doi: 10.1158/1055-9965.EPI-15-1068. Epub 2015 Dec 31.

本文引用的文献

1
The prevalence and correlates of breast cancer among women in Eastern China.中国东部地区女性乳腺癌的患病率及相关因素。
PLoS One. 2012;7(6):e37784. doi: 10.1371/journal.pone.0037784. Epub 2012 Jun 18.
2
Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes.分子亚型分类是前哨淋巴结阳性乳腺癌患者非前哨淋巴结转移的决定因素。
PLoS One. 2012;7(4):e35881. doi: 10.1371/journal.pone.0035881. Epub 2012 Apr 26.
3
The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.乳腺导管原位癌(DCIS)分级对筛检性 DCIS 患者 15 年随访后复发率、类型及时间的影响。
Br J Cancer. 2012 May 8;106(10):1611-7. doi: 10.1038/bjc.2012.151. Epub 2012 Apr 19.
4
Family history and breast cancer hormone receptor status in a Spanish cohort.家族史与西班牙队列乳腺癌激素受体状态
PLoS One. 2012;7(1):e29459. doi: 10.1371/journal.pone.0029459. Epub 2012 Jan 6.
5
The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.分子亚型分类是早期乳腺癌前哨淋巴结阳性的决定因素。
PLoS One. 2011;6(5):e20297. doi: 10.1371/journal.pone.0020297. Epub 2011 May 31.
6
The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysis.家族史和组织学分层对良性乳腺疾病女性乳腺癌风险的影响:一项荟萃分析。
J Cancer Res Clin Oncol. 2011 Jul;137(7):1053-60. doi: 10.1007/s00432-011-0979-z. Epub 2011 Apr 17.
7
Clinical assessment of breast cancer risk based on family history.基于家族史的乳腺癌风险临床评估。
J Natl Compr Canc Netw. 2010 Oct;8(10):1148-55. doi: 10.6004/jnccn.2010.0084.
8
Ductal carcinoma in situ: risk factors and impact of screening.导管原位癌:危险因素及筛查的影响
J Natl Cancer Inst Monogr. 2010;2010(41):113-6. doi: 10.1093/jncimonographs/lgq024.
9
Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.一级亲属乳腺癌家族史与三阴性乳腺癌风险。
Breast Cancer Res Treat. 2011 Apr;126(3):671-8. doi: 10.1007/s10549-010-1148-9. Epub 2010 Sep 3.
10
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients.中国乳腺癌患者三阴性肿瘤的临床病理特征
Breast Cancer Res Treat. 2009 May;115(2):325-33. doi: 10.1007/s10549-008-0096-0. Epub 2008 Jun 18.